Company profile for Ascendia Pharmaceuticals

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Ascendia is a specialty pharmaceutical company dedicated to developing enhanced formulations of existing drug products, and enabling formulations for pre-clinical and clinical stage drug candidates. Established in 2012 by Jingjun “Jim” Huang, Ascendia provides state-of-the-art formulation development services for poorly water soluble molecules. Applying its nano-particle technologies and expertise, Ascendia can rapidly a...
Ascendia is a specialty pharmaceutical company dedicated to developing enhanced formulations of existing drug products, and enabling formulations for pre-clinical and clinical stage drug candidates. Established in 2012 by Jingjun “Jim” Huang, Ascendia provides state-of-the-art formulation development services for poorly water soluble molecules. Applying its nano-particle technologies and expertise, Ascendia can rapidly assess the feasibility of a broad array of formulation options in order to improve a drug’s bioavailability. We execute rapid, comprehensive, and cost-effective programs for our clients. We partner with emerging, discovery-stage pharmaceutical companies to provide early-stage formulations, with generic companies that seek enabling technology, and with specialty pharmaceutical companies that need development of a product for clinical testing. Our technologies include nano-emulsions, amorphous solid dispersions, and production of nano-particles Ascendia provides development and testing services - from discovery-stage molecules to life-cycle-management projects - creating formulation solutions with enhanced biopharmaceutical properties suitable for clinical scale-up.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
675 US Highway One, North Brunswick, NJ 08902
Telephone
Telephone
(732) 640-0058
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Tides Asia

Tides Asia

Not Confirmed

envelop Contact Supplier

Tides Asia

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.prnewswire.com/news-releases/ascendia-pharmaceutical-solutions-launched-to-meet-drug-development-and-manufacturing-needs-302326573.html

PR NEWSWIRE
09 Dec 2024

https://www.prnewswire.com/news-releases/ascendia-named-to-2023-inc-5000-list-of-americas-fastest-growing-private-companies-for-the-fourth-consecutive-year-301909569.html

PR NEWSWIRE
24 Aug 2023

https://www.prnewswire.com/news-releases/ascendia-pharmaceuticals-develops-novel-nanoemulsion-iv-formulation-for-clopidogrel-that-received-ind-approval-301864894.html

PR NEWSWIRE
27 Jun 2023

https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-june-2-2021-1622637119.pdf

FDA
02 Jun 2021

https://www.contractpharma.com/contents/view_breaking-news/2021-04-09/ascendia-pharmaceuticals-poised-for-expansion/?widget=listSection

CONTRACTPHARMA
09 Apr 2021

https://www.prnewswire.com/news-releases/ascendia-pharmaceuticals-secures-growth-equity-investment-from-signet-healthcare-partners-301265086.html

PRNEWSWIRE
08 Apr 2021

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty